Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback